Advance in mechanism of the surgical treatment for type 2 diabetes mellitus

Abstract

Abstract: Type 2 diabetes mellitus shows an upward trend year by year.At present,more mature treatment is still oral hypoglycemic drugs.However,hypoglycemic drugs are not able to prevent complications. More research proves that the Surgery treatment on type 2 diabetic rats have an significant effection for type 2 diabetes(T2DM) treatment.Surgical treatment provides a new way on 2 diabetes treatment,but we still do not know the mechanism of the surgical treatment. This paper mainly reviewed therapy mechanism of the treatment of type 2 diabetes mellitus.

Key words: Type 2 diabetes, Surgery treatment, Mechanism

CLC Number:

R587

WEI Qiang, HUANG He. Advance in mechanism of the surgical treatment for type 2 diabetes mellitus[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(11): 1310-1314.

References

[1] Shaw JE,Sicree RA,Zimmet PZ.Global estimates of the preva-lence of diabetes for 2010 and 2030[J].Diabetes Res Clin Pract,2010,87(1):4-14.
[2] Mason EE,Ho C.Gastric bypass in obesity[J].Surg Clin Noah Am,1967,47(6):1345-1351.
[3] Bariatric surgery reduces type 2 diabetes risk in obese individuals[J]. Harv Health Lett, 2012,38(1):8.
[4] McKinney M. Medical innovations: weight-loss surgery for diabetes tops list[J]. Mod Healthc, 2012,42(45):16-17.
[5] Ludwig DS, Ebbeling CB, Livingston EH.Related citations surgical vs lifestyle treatment for type 2 diabetes[J]. JAMA, 2012,308(10):981-982.
[6] 李勋,魏寿江,沈俊,等.胃转流术治疗2型糖尿病疗效观察-附17例报告[J].川北医学院学报,2011,26(1):14-15.
[7] Admiraal WM, Celik F, Gerdes VE, et al. Ethnic differences in weight loss and diabetes remission after bariatric surgery: a meta-analysis[J]. Diabetes Care, 2012,35(9):1951-1958.
[8] Hall TC,Pellen MG,Sedman PC,et al.Preoperative factors predictingremission of type 2 diabetes mellitus after Roux-en-Y gastricbypass surgery for obesity[J].Obes Surg, 2010,20(9):1245-1250.
[9] Vidal J,Ibarzabal A,Romero F,et al.Type 2 diab etes mellitusand the metabolic syndrome following sleeve gastrectomy in severelyobese subjects[J].Obes Surg,2008,18(9):1077-1082.
[10] Lakdawala M,Bhasker A;Asian Consensus Meeting on Metabolic Surgery (ACMOMS).Report:Asian consensus meeting on met-abolic surgery.Recommendations for the use of bariatrie and Gas-trointestinal metabolic surgery for treatment of obesity and typeⅡ diabetes mellitus in the asian population:August 9th and loth,2008,Trivandrum,India[J].Obes Surg,2010,20(7):929-936.
[11] Ramos AC, Galvao Neto MP, de Souza YM, et al.Laparoscopic duodenal-jejunal exclusion in the treatment of type2 diabetes mellitus in patients with BMI<30 kg／m (LBMI) [J].Obes Surg,2009,19(3):307-3l2.
[12] Lima J,Helena L,Oliveira S,et al.Rapid resolution of diabetes after gastric bypass[J].Obes Surg,2005,15(3):448-449.
[13] Rubino F,Gagner M ,Gentileschi P,et al.The early efect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose[J].Ann Surg,2004, 240(2):236-242.
[14] Drucker DJ.The role of gut hormones in glucose homeostasis[J].J Clin Invest,2007,117(1):24-32.
[15] Cmmings BP, Strader AD,Stanhope KL,et al. interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat[J].Gastroenterology,2010,138(7):2437-2446.
[16] Huang CK. Single-incision laparoscopic bariatric surgery[J].J Min Access Surg,2011,7:99-103.
[17] Patfiti A,Facchiano E,Annetti C,et al.Early improvement of glucose tolerance after ileal transposition in a nor-obese type 2 diabetes rat model[J].Obes Surg,2005,15(9):1258-1264.
[18] Rubino F,Marescaux J.Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes:a new perspective for an old disease[J].Ann Surg,2004,239(1):1-11.
[19] Cummings DE,Overduin J,Foster-Schubert KE.Gastric bypass for obesity:mechanisms ofweightloss and diabetes resolution[J]. J Clin Endocrinol Metab,2004,89(6):2608-2615.
[20] Rubino F,Zizzari P,Tomasetto C,et al.The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat[J].Endocrinology,2005,146(4):1745-1751.
[21] Lebovit HE. Science, clinical outcomes and the popularization of diabetes surgery[J]. Curr Opin Endocrinol Diabetes Obes,2012 ,19(5):359-366.
[22] Rubino F,Forgione A,Cummings DE,et al.The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes[J].Ann Surg,2006,244(5):741-749.
[23] Mason EE.The mechanisms of surgical treatment of type 2 diabetes[J].Obes Surg,2005,15(4):459-461.
[24] Pories WJ, Albrecht RJ.Etiology of type II diabetes reellitus:role of the foregut[J].World J Surg,2001,25(4):527-531.
[25] Rubino F, Gagner M.Potential of surgery for curing type 2 diabetes mellitus[J].Ann Surg,2002,236(5):554-559.
[26] Rubino F, Gagner M, Gentileschi P, et al.The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and ducose metabolism[J].Ann Surg,2004,240(2):236-242.
[27] Kindel TL,Yoder SM,Seeley RJ, et al.Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism[J]. J Gastrointest Surg,2009,13(10):1762-1772.
[28] Fried M,Ribaric G,Buchwald JN,et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI ＜35 kg/m² : an integrative review of early studies[J]. Obes Surg,2010,20(6) : 776-790.
[29] 徐定银,金凯,钱建中.胃旁路转流术对实验性2型糖尿病大鼠胰岛素抵抗的影响[J].中国现代医生,2011,49(3):3-5.
[30] Wang PY,Caspi L,Lain CK,et al.Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production[J].Nature,2008,452(7190):1012-1016.
[31] Whitson BA,Leslie DB,Kellogg TA,et al.Entero-endocrine changes after gastric byp ass in diabetic and nondiabetic patients:a prelminary study[J].J Surg Res,2007,141(1):31-39.
[32] Cummings DE,Overduin J.Gastrointestinal regulation of food intake[J].J Clin Invest,2007,117(1):13-23.